Integrated analysis of two phase 2 trials of nivolumab in metastatic rare solid cancer with dMMR or pMMR (MASTER KEY sub-studies: ROCK and ROLL trial).

被引：0

作者：

Kanai, Masashi

Okuma, Hitomi Sumiyoshi

Tsuchihashi, Kenji

Machida, Ryunosuke

Sadachi, Ryo

Hirakawa, Akihiro

Kamikura, Masahisa

Anjo, Kenta

Sekine, Shigeki

Okita, Natsuko Tsuda

Nakamura, Kenichi

Yonemori, Kan

机构：

[1] Kyoto Univ Hosp, Dept Med Oncol, Kyoto, Japan

[2] Natl Canc Ctr, Clin Res Support Off, Tokyo, Japan

[3] Kyushu Univ Hosp, Dept Hematol Oncol & Cardiovasc Med, Fukuoka, Japan

[4] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Clin Biostat, Tokyo, Japan

[5] Natl Canc Ctr, Dept Diagnost Pathol, Tokyo, Japan

[6] Natl Canc Ctr, Dept Med Oncol, Tokyo, Japan

来源：

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

e14603

引用

页数：1

共 2 条